210 related articles for article (PubMed ID: 38485792)
1. Genomic technologies for detecting structural variations in hematologic malignancies.
Jang MA
Blood Res; 2024 Feb; 59(1):1. PubMed ID: 38485792
[TBL] [Abstract][Full Text] [Related]
2. Novel precision medicine approaches and treatment strategies in hematological malignancies.
Rosenquist R; Bernard E; Erkers T; Scott DW; Itzykson R; Rousselot P; Soulier J; Hutchings M; Östling P; Cavelier L; Fioretos T; Smedby KE
J Intern Med; 2023 Oct; 294(4):413-436. PubMed ID: 37424223
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide arrays in routine diagnostics of hematological malignancies.
Simons A; Sikkema-Raddatz B; de Leeuw N; Konrad NC; Hastings RJ; Schoumans J
Hum Mutat; 2012 Jun; 33(6):941-8. PubMed ID: 22488943
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.
Fukuhara S; Oshikawa-Kumade Y; Kogure Y; Shingaki S; Kariyazono H; Kikukawa Y; Koya J; Saito Y; Tabata M; Yoshifuji K; Mizuno K; Miyagi-Maeshima A; Matsushita H; Sugiyama M; Ogawa C; Inamoto Y; Fukuda T; Sugano M; Yamauchi N; Minami Y; Hirata M; Yoshida T; Kohno T; Kohsaka S; Mano H; Shiraishi Y; Ogawa S; Izutsu K; Kataoka K
Cancer Sci; 2022 Aug; 113(8):2763-2777. PubMed ID: 35579198
[TBL] [Abstract][Full Text] [Related]
5. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
Navrkalova V; Plevova K; Hynst J; Pal K; Mareckova A; Reigl T; Jelinkova H; Vrzalova Z; Stranska K; Pavlova S; Panovska A; Janikova A; Doubek M; Kotaskova J; Pospisilova S
J Mol Diagn; 2021 Aug; 23(8):959-974. PubMed ID: 34082072
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA.
Coccaro N; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Minervini CF; Minervini A; Conserva MR; Redavid I; Parciante E; Macchia MG; Specchia G; Musto P; Albano F
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296693
[TBL] [Abstract][Full Text] [Related]
7. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
[TBL] [Abstract][Full Text] [Related]
8. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
[TBL] [Abstract][Full Text] [Related]
9. Appraisal of current technologies for the study of genetic alterations in hematologic malignancies with a focus on chromosome analysis and structural variants.
Salaverria I; Siebert R; Mrózek K
Med Genet; 2024 Apr; 36(1):13-20. PubMed ID: 38835966
[TBL] [Abstract][Full Text] [Related]
10. Molecular Diagnostic Testing for Hematopoietic Neoplasms: Linking Pathogenic Drivers to Personalized Diagnosis.
Hergott CB; Kim AS
Clin Lab Med; 2022 Sep; 42(3):325-347. PubMed ID: 36150815
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetics in the genomic era.
Granada I; Palomo L; Ruiz-Xivillé N; Mallo M; Solé F
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101196. PubMed ID: 33038985
[TBL] [Abstract][Full Text] [Related]
12. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Tansatit M
Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.
Galanina N; Bejar R; Choi M; Goodman A; Wieduwilt M; Mulroney C; Kim L; Yeerna H; Tamayo P; Vergilio JA; Mughal TI; Miller V; Jamieson C; Kurzrock R
Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30583461
[No Abstract] [Full Text] [Related]
14. Intracranial hematolymphoid malignancies: A case series with molecular characterization.
Langston RG; Pinckard-Dover H; Guzman G; Wardell CP; Gokden M; Morris TW; Day JD; Rodriguez A
Clin Neurol Neurosurg; 2023 Oct; 233():107928. PubMed ID: 37573681
[TBL] [Abstract][Full Text] [Related]
15. The landscape of cytogenetic and molecular genetic methods in diagnostics for hematologic neoplasia.
Behrens YL; Pietzsch S; Antić Ž; Zhang Y; Bergmann AK
Best Pract Res Clin Haematol; 2024 Mar; 37(1):101539. PubMed ID: 38490767
[TBL] [Abstract][Full Text] [Related]
16. Guiding the global evolution of cytogenetic testing for hematologic malignancies.
Akkari YMN; Baughn LB; Dubuc AM; Smith AC; Mallo M; Dal Cin P; Diez Campelo M; Gallego MS; Granada Font I; Haase DT; Schlegelberger B; Slavutsky I; Mecucci C; Levine RL; Hasserjian RP; Solé F; Levy B; Xu X
Blood; 2022 Apr; 139(15):2273-2284. PubMed ID: 35167654
[TBL] [Abstract][Full Text] [Related]
17. Cytogenomics of B-cell non-Hodgkin lymphomas: The "old" meets the "new".
Grau M; López C; Martín-Subero JI; Beà S
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101513. PubMed ID: 38092483
[TBL] [Abstract][Full Text] [Related]
18. [Recent advancements in molecular cytogenetics for hematological malignancies: identification of novel PVT1 fusion genes].
Taniwaki M
Rinsho Ketsueki; 2015 Oct; 56(10):2056-65. PubMed ID: 26458445
[TBL] [Abstract][Full Text] [Related]
19. [NGS-based multi-gene panel testing in hematological malignancies: diagnosis and prognostic prediction].
Tanigawa T; Kataoka K
Rinsho Ketsueki; 2022; 63(4):294-301. PubMed ID: 35491219
[TBL] [Abstract][Full Text] [Related]
20. Towards precision medicine in lymphoid malignancies.
Bühler MM; Martin-Subero JI; Pan-Hammarström Q; Campo E; Rosenquist R
J Intern Med; 2022 Aug; 292(2):221-242. PubMed ID: 34875132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
